Авторы

  • Шукурхужаева Д.Н.

Ключевые слова:

синдром ограничения роста плода; ангиогенез; биомаркер; PlGF; беременность; перинатальные исходы; плацента.

Библиографические ссылки

1. Agha M.M., Glazier R.H., Moineddin R., Booth G. Congenital abnormalities in newborns of women with pregestational diabetes: A time-trend analysis, 1994 to 2009. Birth Defects Res. 2016; 106:831–839. doi: 10.1002/bdra. 23548.

2. Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH: Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011;31:66–74.

3. Alexander G.R., Himes J.H., Kaufman R.B., Mor J., Kogan M. A United States reference for fetal growth. Obstet. Gynecol. 1996; 87:163–168. doi: 10.1016/0029-7844(95)00386-X.

4. Al-Qahtani M. Infants of Diabetic Mothers: 4 Years Analysis of Neonatal Care Unit in a Teaching Hospital, Saudi Arabia. Saudi J. Med. Med. Sci. 2014; 2:151–156. doi: 10.4103/1658-631X.142499.

5. American Diabetes Association Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41: S137–S143. doi: 10.2337/dc18-S013.

6. Balsells M., García-Patterson A., Gich I., Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: A systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 2009;94:4284–4291. doi: 10.1210/jc. 2009-1231.

7. Barnabe C, Faris PD, Quan H: Canadian pregnancy outcomes in rheumatoid arthritis and systemic lupus erythematosus. Int J Rheumatol 2011 (E-pub ahead of print).

8. Beyerlein A., von Kries R., Hummel M., Lack N., Schiessl B., Giani G., Icks A. Improvement in pregnancy-related outcomes in the offspring of diabetic mothers in Bavaria, Germany, during 1987–2007. Diabet. Med. 2010; 27:1379–1384. doi: 10.1111/j.146 4-5491.2010.03109.x.

9. Branch DW, Khamashta MA: Antiphospholipid syndrome: obstetric diagnosis, management, and controversies. Obstet Gynecol 2003;101:1333–1344.

10. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX-XIV.

11. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y: Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis. Obstet Gynecol 2010;116:402–414.

12. Capobianco G., Gulotta A., Tupponi G., Dessole F., Pola M., Virdis G., Petrillo M., Mais V., Olzai G., Antonucci R., et al. Materno-Fetal and Neonatal Complications of Diabetes in Pregnancy: A Retrospective Study. J. Clin. Med. 2020; 9:2707. doi: 10.3390/jcm90 92707.

13. Chen CY, Chen YH, Lin HC, Chen SF, Lin HC: Increased risk of adverse pregnancy outcomes for hospitalisation of women with lupus during pregnancy: a nationwide population-based study. Clin Exp Rheumatol 2010;28:49–55.

14. Clausson B, Cnattingius S, Axelsson O: Preterm and term births of small for gestational age infants: a population-based study of risk factors among nulliparous women. Br J Obstet Gynaecol 1998; 105: 1011–1017.

15. D’Angelo DV, Whitehead N, Helms K, Barfield W, Ahluwalia IB: Birth outcomes of intended pregnancies among women who used assisted reproductive technology, ovulation stimulation, or no treatment. Fertil Steril 2011;96:314–320.

16. Dollberg S., Bauer R., Lubetzky R., Mimouni F.B. A reappraisal of neonatal blood chemistry reference ranges using the Nova M electrodes. Am. J. Perinatol. 2001; 18:433–440. doi: 10.1055/s-2001-187 87.

17. Fadda G.M., Capobianco G., Balata A., Litta P., Ambrosini G., D’Antona D., Cosmi E., Dessole S. Routine second-trimester ultrasound screening for prenatal detection of fetal malformations in Sassari University Hospital, Italy: 23 years of experience in 42,256 pregnancies. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009; 144:110–114. doi: 10.1016/j.ejogrb.200 9.02.045.

18. Gardosi J, Mongelli M, Mul T: Intrauterine growth retardation; in Steegers EAP, Eskes TK, Symonds EM (eds): Preventive Care in Obstetrics and Gynaecology. Baillieres Clin Obstet Gynaecol 1995; 9:445–643.

19. Gardosi J: New definition of small for gestational age based on fetal growth potential. Horm Res 2006;65(suppl):15–18.

20. Garne E., Loane M., Dolk H., Barisic I., Addor M.C., Arriola L., Bakker M., Calzolari E., Matias Dias C., Doray B., et al. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res. 2012; 94:134–140. doi: 10.1002/ bdra. 22886.

21. Gilbert WM, Young AL, Danielsen B: Pregnancy outcomes in women with chronic hypertension: a population-based study. J Reprod Med 2007; 52:1046–1051.

22. Gortazar L., Goday A., Flores-Le Roux J.A., Sarsanedas E., Payà A., Mañé L., Pedro-Botet J., Benaiges D. Trends in prevalence of pre-existing diabetes and perinatal outcomes: A large, population-based study in Catalonia, Spain, 2006–2015. BMJ Open Diabetes Res. Care. 2020;8:e001254. doi: 10.1136/bmjdrc-2020-001254.

23. Hoang T.T., Marengo L.K., Mitchell L.E., Canfield M.A., Agopian A.J. Original Findings and Updated Meta-Analysis for the Association between Maternal Diabetes and Risk for Congenital Heart Disease Phenotypes. Am. J. Epidemiol. 2017;186:118–128. doi: 10.1093/aje/kwx033.

24. Huppertz B: Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008,51:970–975.

25. Kagan KO, Wright D, Valencia C, Maiz N, Nicolaides KH: Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free β-hCG and pregnancy-associated plasma protein-A. Hum Reprod 2008;23:1968–1975.

26. Kanda E, Matsuda Y, Makino Y, Matsui H: Risk factors associated with altered fetal growth in patients with pregestational diabetes mellitus. J Matern Fetal Neonatal Med 2012 (E-pub ahead of print).

27. Karagiannis G, Akolekar R, Sarquis R, Wright D, Nicolaides KH: Prediction of small-for-gestation neonates from biophysical and biochemical markers at 11–13 weeks. Fetal Diagn Ther 2011; 29: 148–154.

28. Kheir A.E., Berair R., Gulfan I.G., Karrar M.Z., Mohammed Z.A. Morbidity and mortality amongst infants of diabetic mothers admitted into Soba University Hospital, Khartoum, Sudan. Sudan. J. Paediatr. 2012;12:49–55.

29. Kong L., Nilsson I.A.K., Gissler M., Lavebratt C. Associations of Maternal Diabetes and Body Mass Index with Offspring Birth Weight and Prematurity. JAMA Pediatr. 2019; 173:371–378. doi: 10.1001/ jamapediatrics.2018.5541.

30. Li Y., Wang W., Zhang D. Maternal diabetes mellitus and risk of neonatal respiratory distress syndrome: A meta-analysis. Acta Diabetol. 2019; 56:729–740. doi: 10.1007/s00592-019-01327-4.

31. Mackin S.T., Nelson S.M., Kerssens J.J., Wood R., Wild S., Colhoun H.M., Leese G.P., Philip S., Lindsay R.S., SDRN Epidemiology Group Diabetes and pregnancy: National trends over 15 years. Diabetologia. 2018; 61:1081–1088. doi: 10.1007/s001 25-017-4529-3.

32. Moosazadeh M., Asemi Z., Lankarani K.B., Tabrizi R., Maharlouei N., Naghibzadeh-Tahami A., Yousefzadeh G., Sadeghi R., Khatibi S.R., Afshari M., et al. Family history of diabetes and the risk of gestational diabetes mellitus in Iran: A systematic review and meta-analysis. Diabetes Metab. Syndr. 2017;11: S99–S104. doi: 10.1016/j.dsx.2016.12.016.

33. Murphy HR, Steel SA, Roland JM, Morris D, Ball V, Campbell PJ, Temple RC; East Anglia Study Group for Improving Pregnancy Outcomes in Women with Diabetes (EASIPOD): Obstetric and perinatal outcomes in pregnancies complicated by type 1 and type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med 2011;28:1060–1067.

34. Nicolaides KH: Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 2011;31:7–15.

35. Nicolaides KH: Turning the pyramid of prenatal care. Fetal Diagn Ther 2011;29:183–196.

36. Orbain M.M., Johnson J., Nance A., Romeo A.N., Silver M.A., Martinez L., Leen-Mitchell M., Carey J.C. Maternal diabetes-related malformations in Utah: A population study of birth prevalence 2001–2016. Birth Defects Res. 2021;113:152–160. doi: 10.1002/bdr2.1843.

37. Pandya P, Wright D, Syngelaki A, Akolekar R, Nicolaides KH: Maternal serum placental growth factor in prospective screening for aneuploidies at 8–13 weeks’ gestation. Fetal Diagn Ther 2012 (E-pub ahead of print).

38. Parimi M., Nitsch D. A systematic review and meta-analysis of diabetes during pregnancy and congenital genitourinary abnormalities. Kidney Int. Rep. 2020; 5:678–693. doi: 10.1016/j.ekir.2020.02. 1027.

39. Plasencia W, Maiz N, Bonino S, Kaihura C, Nicolaides KH: Uterine artery Doppler at 11+0 to 13+6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2007;30:742–749.

40. Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH: Reference range of birth weight with gestation and first-trimester prediction of small-for-gestation neonates. Prenat Diagn 2011; 31:58–65.

41. Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH: Birthweight with gestation and maternal characteristics in live births and stillbirths. Fetal Diagn Ther 2012, E-pub ahead of print.

42. Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH: Protocol for measurement of mean arterial pressure at 11–13 weeks’ gestation. Fetal Diagn Ther 2012;31:42–48.

43. Riskin A., Itzchaki O., Bader D., Iofe A., Toropine A., Riskin-Mashiah S. Perinatal Outcomes in Infants of Mothers with Diabetes in Pregnancy. Isr. Med. Assoc. J. 2020;22:569–575.

44. Roberge S, Villa P, Nicolaides K, Giguère Y, Vainio M, Bakthi A, Ebrashy A, Bujold E: Early administration of low-dose aspirin for the prevention of preterm and term pre-eclampsia: a systematic review and meta-analysis. Fetal Diagn Ther 2012; 31: 141–146.

45. Robinson HP, Fleming JE: A critical evaluation of sonar ‘crown-rump length’ measurements. Br J Obstet Gynaecol 1975;82:702–710.

46. Royal College of Obstetricians and Gynaecologists. The Investigation and Management for the Small for Gestational Age Fetus (Guidelines 31) Royal College of Obstetricians and Gynaecologists; London, UK: 2002.

47. Shefali A.K., Kavitha M., Deepa R., Mohan V. Pregnancy outcomes in pre-gestational and gestational diabetic women in comparison to non-diabetic women: A prospective study in Asian Indian Mothers (CURES-35) J. Assoc. Physicians India. 2006;54:613–618.

48. Shub A., Lappas M. Pregestational diabetes in pregnancy: Complications, management, surveillance, and mechanisms of disease—A review. Prenat. Diagn. 2020;40:1092–1098. doi: 10.1002/pd. 5718.

49. Songini M., Muntoni S. High incidence of type 1 diabetes in Sardinia. Lancet. 1991;337:1047. doi: 10.1016/0140-6736(91)92714-D.

50. Sugiyama T., Nagao K., Metoki H., Nishigori H., Saito M., Tokunaga H., Nagase S., Sugawara J., Watanabe Y., Yaegashi N., et al. Pregnancy outcomes of gestational diabetes mellitus according to pre-gestational BMI in a retrospective multi-institutional study in Japan. Endocr. J. 2014;61:373–380. doi: 10. 1507/endocrj.EJ13-0541.

51. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP, Davis RO, DuBard MB: Smoking, maternal age, fetal growth, and gestational age at delivery. Am J Obstet Gynecol 1990;162:53–58.

52. Wright D, Akolekar R, Syngelaki A, Poon LCY, Nicolaides KH: A competing risks model in early screening for preeclampsia. Fetal Diagn Ther 2012, E-pub ahead of print.